These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27329850)

  • 21. Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.
    Kim AS; Leaman DP; Zwick MB
    PLoS Pathog; 2014 Jul; 10(7):e1004271. PubMed ID: 25058619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
    Soto C; Ofek G; Joyce MG; Zhang B; McKee K; Longo NS; Yang Y; Huang J; Parks R; Eudailey J; Lloyd KE; Alam SM; Haynes BF; ; Mullikin JC; Connors M; Mascola JR; Shapiro L; Kwong PD
    PLoS One; 2016; 11(6):e0157409. PubMed ID: 27299673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.
    Liu H; Su X; Si L; Lu L; Jiang S
    Protein Cell; 2018 Jul; 9(7):596-615. PubMed ID: 29667004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
    Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope-vaccines: a new strategy to induce high levels of neutralizing antibodies against HIV-1.
    Xiao Y; Liao M; Lu Y; Dierich MP; Chen YH
    Immunobiology; 2000 Jan; 201(3-4):323-31. PubMed ID: 10776789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy.
    Law M; Cardoso RM; Wilson IA; Burton DR
    J Virol; 2007 Apr; 81(8):4272-85. PubMed ID: 17267498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.
    Banerjee S; Shi H; Habte HH; Qin Y; Cho MW
    Virology; 2016 Mar; 490():17-26. PubMed ID: 26803471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1.
    Lu Y; Xiao Y; Ding J; Dierich M; Chen YH
    Int Arch Allergy Immunol; 2000 Jan; 121(1):80-4. PubMed ID: 10686512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
    Zhou M; Kostoula I; Brill B; Panou E; Sakarellos-Daitsiotis M; Dietrich U
    Vaccine; 2012 Mar; 30(11):1911-6. PubMed ID: 22269872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration.
    Li QH; Jin G; Wang JY; Li HN; Liu H; Chang XY; Wang FX; Liu SL
    Sci Rep; 2016 Jul; 6():29556. PubMed ID: 27411313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120.
    Ampol S; Pattanapanyasat K; Sutthent R; Permpikul P; Kantakamalakul W
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1250-8. PubMed ID: 22288892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and specificity of the candidate multi-epitope-vaccines against HIV-1.
    Lu Y; Ding J; Chen YH
    Immunopharmacol Immunotoxicol; 2001 Nov; 23(4):487-94. PubMed ID: 11792008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.
    Zhang L; Miao L; Gong X; Zhang H; Yang L; Shi Y; Kong W; Jiang C; Shan Y
    J Pept Sci; 2013 Aug; 19(8):491-8. PubMed ID: 23794478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Melnychuk L; Ajamian L; Jean-Pierre P; Liang J; Gheorghe R; Wainberg MA; Zaharatos GJ
    Vaccine; 2017 May; 35(20):2736-2744. PubMed ID: 28392143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.
    Brunel FM; Zwick MB; Cardoso RM; Nelson JD; Wilson IA; Burton DR; Dawson PE
    J Virol; 2006 Feb; 80(4):1680-7. PubMed ID: 16439525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.
    Correia BE; Ban YE; Holmes MA; Xu H; Ellingson K; Kraft Z; Carrico C; Boni E; Sather DN; Zenobia C; Burke KY; Bradley-Hewitt T; Bruhn-Johannsen JF; Kalyuzhniy O; Baker D; Strong RK; Stamatatos L; Schief WR
    Structure; 2010 Sep; 18(9):1116-26. PubMed ID: 20826338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.